CEDAR PARK, Texas, Oct. 05, 2025 (GLOBE NEWSWIRE) -- Firefly Aerospace (Nasdaq: FLY), a market leading space and defense technology company, has entered into a definitive agreement to acquire SciTec, Inc., a leader in advanced national security technologies, for approximately $855 million through a combination of $300 million in cash and $555 million in Firefly shares issued to SciTec owners at a price of $50 per share. “The acquisition of SciTec enhances our ability to support a growing number of defense ...

– ARV-102 was well tolerated in clinical trials for both healthy volunteers and patients with Parkinson’s disease – – ARV-102 demonstrated dose-dependent cerebrospinal fluid (CSF) exposure in subjects in both trials – – After 14 days of treatment in healthy volunteers, ARV-102 decreased lysosomal and neuroinflammatory microglial pathway biomarkers known to be elevated in Parkinson’s disease – NEW HAVEN, Conn., Oct. 05, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology com ...

NEW YORK, Oct. 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 and July 3, 2025, both dates inclusive (the “Class Period”), of the important November 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Jasper Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingen ...

集体诉讼案件背景 - Rosen Law Firm提醒在2025年7月15日至2025年8月14日期间购买Fly-E Group, Inc (NASDAQ: FLYE) 证券的投资者注意2025年11月10日的首席原告截止日期 [1] - 投资者可能无需支付任何自付费用即可获得赔偿 [1] - 针对Fly-E的集体诉讼已被提起 [2] 诉讼指控细节 - 指控Fly-E公司在诉讼期间向投资者提供了过于积极的陈述 同时传播了重大虚假和误导性声明 和/或隐瞒了有关其锂电池安全性的重大不利事实 [4] - 据称 锂电池安全问题对Fly-E的电动汽车销售收入造成了重大影响 [4] - 尽管做出了宏伟的长期预测 但Fly-E的预测流程存在不足 销售持续下滑且运营费用增加 最终导致其收入预测脱轨 [4] - 当真实情况进入市场时 投资者遭受了损失 [4] 律所资质声明 - Rosen Law Firm在全球范围内代表投资者 专注于证券集体诉讼和股东派生诉讼 [3] - 该律所曾达成针对中国公司的史上最大证券集体诉讼和解 [3] - 该律所自2013年以来每年排名前四 已为投资者追回数亿美元 仅在2019年就为投资者确保了超过4.38亿美元 [3]

NEW YORK, Oct. 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fluor Corporation (NYSE: FLR) between February 18, 2025 and July 31, 2025, both dates inclusive (the “Class Period”), of the important November 14, 2025 lead plaintiff deadline. SO WHAT: If you purchased Fluor securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT ...

NEW YORK, Oct. 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Semler Scientific, Inc. (NASDAQ: SMLR) between March 10, 2021 and April 15, 2025, both dates inclusive (the “Class Period”), of the important October 28, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Semler Scientific securities during the Class Period you may be entitled to compensation without payment of an ...

文章核心观点 - 基于以太坊的加密货币项目MAGACOIN FINANCE在预售中筹集了超过1550万美元，吸引了超过14000名全球投资者，这反映了在市场对比特币ETF的预期下，资金正流向具有明确代币经济学和预售势头的以太坊项目 [1][4][8] 项目融资里程碑 - 项目已筹集资金超过1550万美元 [1][5][6] - 参与预售的投资者数量超过14000名 [1][6] - 代币分配已完成约80% [6] - 代币发行价格为每个0.007美元 [6] 市场背景与行业趋势 - 市场焦点集中在待定的比特币ETF进展上，这导致资金溢出到像MAGACOIN FINANCE这样的低市值以太坊项目 [4] - 比特币ETF的热潮正在建立，资金流正延伸至山寨币领域 [8] - 该项目1550万美元的融资成就使其成为本轮周期中融资规模最大的早期项目之一 [4] 项目特点与机制 - 项目采用分阶段模型，随着供应量减少逐步提高代币价格，为早期参与者创造了内置的稀缺机制 [3] - 项目结合了文化相关性和可扩展的区块链实用性 [9] - 项目拥有庞大且不断增长的全球社区，其基于以太坊的架构与机构趋势保持一致 [12]

Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data 50 mg once-daily dose of obefazimod led to a pooled 16.4% (p<0.0001) placebo-adjusted clinical remission rate at Week 8; met primary and all key secondary endpoints in both ABTECT 1 and ABTECT 2ABTECT trials enrolled refractory patient population with 47% of participants having prior inadequate response to advanced therapy, among whom 21% had prior inadequate response to JAK inhibitor therapyObefazimod treatm ...

WALTHAM, Mass., Oct. 05, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations for the treatment of Inflammatory Bowel Disease (“IBD”) and other immune-mediated diseases, today announced scientific presentations at the UEGW Congress. “We are excited to share follow-up data out to six months from our Phase 1 study of SPY002, our potential best-in-class anti ...

HONG KONG, Oct. 05, 2025 (GLOBE NEWSWIRE) -- MOG Digitech Holdings Limited (01942.HK) announced the completion of a strategic investment in Luckyins Technology (HongKong) Co., Limited, an emerging force in Hong Kong's insurtech sector. This move marks another significant step for MOG Digitech in driving the digital transformation of the insurance industry and advancing its ongoing strategic layout in Web3 insurance. Luckyins Technology (HongKong) Co., Limited is a tech enterprise focused on optimizing insur ...